½ÃÀ庸°í¼­
»óǰÄÚµå
1672907

½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå : Á¦Ç°º°, ¿ëµµº°, ÃÖÁ¾»ç¿ëÀÚº°, Áö¿ªº°

Cardiac Rhythm Management Devices Market, By Product, By Application, By End users, By Geography

¹ßÇàÀÏ: | ¸®¼­Ä¡»ç: Coherent Market Insights | ÆäÀÌÁö Á¤º¸: ¿µ¹® | ¹è¼Û¾È³» : 2-3ÀÏ (¿µ¾÷ÀÏ ±âÁØ)

    
    
    




¡Ø º» »óǰÀº ¿µ¹® ÀÚ·á·Î Çѱ۰ú ¿µ¹® ¸ñÂ÷¿¡ ºÒÀÏÄ¡ÇÏ´Â ³»¿ëÀÌ ÀÖÀ» °æ¿ì ¿µ¹®À» ¿ì¼±ÇÕ´Ï´Ù. Á¤È®ÇÑ °ËÅ並 À§ÇØ ¿µ¹® ¸ñÂ÷¸¦ Âü°íÇØÁֽñ⠹ٶø´Ï´Ù.

½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ¼¼°è ½ÃÀåÀº 2025³â¿¡ 182¾ï 5,000¸¸ ´Þ·¯, 2032³â¿¡´Â 243¾ï 5,000¸¸ ´Þ·¯¿¡ ´ÞÇÒ °ÍÀ¸·Î ¿¹ÃøµÇ¸ç, 2025-2032³â°£ ¿¬Æò±Õ 4.2% ¼ºÀåÇÒ °ÍÀ¸·Î ¿¹»óµË´Ï´Ù.

º¸°í ¹üÀ§ º¸°í¼­ »ó¼¼ ³»¿ë
±âÁØ ¿¬µµ 2024³â 2025³â ½ÃÀå ±Ô¸ð 182¾ï 5,000¸¸ ´Þ·¯
½ÇÀû µ¥ÀÌÅÍ 2020-2024³â ¿¹Ãø ±â°£ 2025-2032³â
¿¹Ãø ±â°£(2025-2032³â) CAGR 4.20% 2032³â ±Ý¾× ¿¹Ãø 243¾ï 5,000¸¸ ´Þ·¯
±×¸². 2025³â Áö¿ªº° ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå Á¡À¯À²(%)
Cardiac Rhythm Management Devices Market-IMG1

½ÉÀå ¹Úµ¿ °ü¸®¿¡´Â ºü¸¥ ½ÉÀå ¹Úµ¿, ´À¸° ½ÉÀå ¹Úµ¿, ºÒ±ÔÄ¢ÇÑ ½ÉÀå ¹Úµ¿ÀÇ Áø´Ü, Ä¡·á ¹× ¿¹¹æÀÌ Æ÷ÇԵ˴ϴÙ. ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í Àü ¼¼°è ³ëÀÎ Àα¸ Áõ°¡´Â ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡¿¡ ´ëÇÑ ¼ö¿ä¸¦ Áõ°¡½Ãų ¼ö ÀÖ½À´Ï´Ù. ±â¼úÀÇ ¹ßÀüÀ¸·Î ¼ÒÇüÈ­µÈ À̽ÄÇü ±â±âÀÇ °³¹ßÀÌ °¡´ÉÇØÁ® ȯÀÚµéÀÇ »îÀÇ ÁúÀ» Çâ»ó½Ãų ¼ö ÀÖ°Ô µÇ¾ú½À´Ï´Ù. ±×·¯³ª ¼ö¼ú ¹× ÀåºñÀÇ ³ôÀº ºñ¿ëÀº ½ÃÀå ¼ºÀåÀ» ÀúÇØÇÏ´Â ¿äÀÎÀ¸·Î ÀÛ¿ëÇÒ ¼ö ÀÖ½À´Ï´Ù. ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀåÀÇ ¼ºÀåÀº ½ÅÈï±¹¿¡¼­ÀÇ Á¦Ç° ½ÂÀÎ Áõ°¡¿Í È®´ë°¡ ÁÖµµÇϰí ÀÖ½À´Ï´Ù.

½ÃÀå ¿ªÇÐ

½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ¼¼°è ½ÃÀå °³Ã´Àº ½ÉÀå ¸®µë ÀÌ»ó°ú °ü·ÃµÈ ½ÉÇ÷°ü ÁúȯÀÇ À¯º´·ü Áõ°¡¿Í ÷´Ü À̽ÄÇü ±â±â °³¹ß·Î À̾îÁö´Â ±â¼ú ¹ßÀüÀÌ ¿øµ¿·ÂÀÌ µÇ°í ÀÖÀ¸¸ç, ¼¼°èº¸°Ç±â±¸(WHO)¿¡ µû¸£¸é ½ÉÇ÷°ü ÁúȯÀ¸·Î ÀÎÇÑ ¿¬°£ »ç¸ÁÀÚ ¼ö´Â 1,700¸¸ ¸íÀ» ³Ñ¾î¼¹À¸¸ç, ±× Áß ´ëºÎºÐÀÌ ºÎÁ¤¸ÆÀ¸·Î ÀÎÇÑ »ç¸ÁÀÚÀÔ´Ï´Ù. ºÎÁ¤¸ÆÀÌ ¿øÀÎÀÔ´Ï´Ù. °í·ÉÈ­·Î ÀÎÇØ ºÎÁ¤¸ÆÀÇ ¹ßº´ À§ÇèÀÌ ³ô¾ÆÁü¿¡ µû¶ó °í·ÉÀÚ °³¹ßµµ ½ÃÀå °³Ã´ÀÇ ¿øµ¿·ÂÀÌ µÇ°í ÀÖ½À´Ï´Ù. ±×·¯³ª ÷´Ü À̽ÄÇü ÀåÄ¡ÀÇ ³ôÀº °¡°Ý°ú ÀÌ½Ä ¼ö¼úÀÌ ½ÃÀå ¼ºÀå¿¡ °É¸²µ¹ÀÌ µÉ ¼ö ÀÖ½À´Ï´Ù. ½ÃÀå ÁøÃâ±â¾÷µéÀº º¸´Ù »õ·Î¿î ¿ëµµÀÇ Çõ½ÅÀûÀÎ µð¹ÙÀ̽ºÀÇ ½ÂÀÎÀ» ȹµæÇϰí, ´ë¸®Á¡°úÀÇ Á¦ÈÞ ¹× JV¸¦ ÅëÇØ ¾Æ½Ã¾ÆÅÂÆò¾ç, ¶óƾ¾Æ¸Þ¸®Ä«, Áßµ¿ ¹× ¾ÆÇÁ¸®Ä«ÀÇ ½ÅÈï ±¹°¡·Î ÁøÃâÇÔÀ¸·Î½á »õ·Î¿î ±âȸ¸¦ È®ÀÎÇÒ ¼ö ÀÖ½À´Ï´Ù.

º» Á¶»çÀÇ ÁÖ¿ä Æ¯Â¡

¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡(Heart Rhythm Management Device) ½ÃÀå¿¡ ´ëÇØ Á¶»ç ºÐ¼®ÇßÀ¸¸ç, 2024³âÀ» ±âÁØ ¿¬µµ·Î ÇÏ¿© ¿¹Ãø ±â°£(2025-2032³â) ½ÃÀå ±Ô¸ð(10¾ï ´Þ·¯)¿Í ¿¬Æò±Õ ¼ºÀå·ü(CAGR)À» Á¶»çÇÏ¿© ÀüÇØµå¸³´Ï´Ù.

¶ÇÇÑ, ´Ù¾çÇÑ ºÎ¹®¿¡ °ÉÄ£ ÀáÀçÀû ¼öÀÍ ±âȸ¸¦ ¹àÈ÷°í, ÀÌ ½ÃÀåÀÇ ¸Å·ÂÀûÀÎ ÅõÀÚ Á¦¾È ¸ÅÆ®¸¯½º¸¦ ¼³¸íÇÕ´Ï´Ù.

¶ÇÇÑ ½ÃÀå ¼ºÀå ÃËÁø¿äÀÎ, ¾ïÁ¦¿äÀÎ, ±âȸ, ½ÅÁ¦Ç° Ãâ½Ã ¹× ½ÂÀÎ, ½ÃÀå µ¿Çâ, Áö¿ªº° Àü¸Á, ÁÖ¿ä ±â¾÷ÀÇ °æÀï Àü·« µî¿¡ ´ëÇÑ Áß¿äÇÑ °íÂûÀ» Á¦°øÇÕ´Ï´Ù.

ÀÌ º¸°í¼­´Â ±â¾÷ ÇÏÀ̶óÀÌÆ®, Á¦Ç° Æ÷Æ®Æú¸®¿À, ÁÖ¿ä ÇÏÀ̶óÀÌÆ®, À繫 ¼º°ú, Àü·« µîÀÇ ¸Å°³ º¯¼ö¸¦ ±â¹ÝÀ¸·Î ¼¼°è ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀåÀÇ ÁÖ¿ä ±â¾÷ ÇÁ·ÎÆÄÀÏÀ» Á¦°øÇÕ´Ï´Ù.

ÁÖ¿ä ±â¾÷À¸·Î´Â Medtronic, Abbott, Boston Scientific, BIoTronik, LivaNova µîÀÌ ÀÖ½À´Ï´Ù.

ÀÌ º¸°í¼­ÀÇ ÀλçÀÌÆ®¸¦ ÅëÇØ ¸¶ÄÉÆÃ ´ã´çÀÚ¿Í ±â¾÷ °æ¿µÁøÀº ÇâÈÄ Á¦Ç° Ãâ½Ã, À¯ÇüÈ­, ½ÃÀå È®´ë, ¸¶ÄÉÆÃ Àü·«¿¡ ´ëÇÑ Á¤º¸¿¡ ÀÔ°¢ÇÑ ÀÇ»ç°áÁ¤À» ³»¸± ¼ö ÀÖ½À´Ï´Ù.

½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ¼¼°è ½ÃÀå º¸°í¼­´Â ÅõÀÚÀÚ, °ø±Þ¾÷ü, Á¦Ç° Á¦Á¶¾÷ü, À¯Åë¾÷ü, ½Å±Ô ½ÃÀå ÁøÃâ±â¾÷, À繫 ºÐ¼®°¡ µî ÀÌ »ê¾÷ÀÇ ´Ù¾çÇÑ ÀÌÇØ°ü°èÀÚ¸¦ ´ë»óÀ¸·Î ÇÕ´Ï´Ù.

ÀÌÇØ°ü°èÀÚµéÀº ¼¼°è ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå ºÐ¼®¿¡ »ç¿ëµÇ´Â ´Ù¾çÇÑ Àü·« ¸ÅÆ®¸¯½º¸¦ ÅëÇØ ÀÇ»ç°áÁ¤À» ½±°Ô ³»¸± ¼ö ÀÖ½À´Ï´Ù.

¸ñÂ÷

Á¦1Àå Á¶»ç ¸ñÀû°ú ÀüÁ¦Á¶°Ç

  • Á¶»ç ¸ñÀû
  • ÀüÁ¦Á¶°Ç
  • ¾à¾î

Á¦2Àå ½ÃÀå Àü¸Á

  • º¸°í¼­ ¼³¸í
    • ½ÃÀå Á¤ÀÇ¿Í ¹üÀ§
  • ÁÖ¿ä ¿ä¾à
  • Coherent Opportunity Map (COM)

Á¦3Àå ½ÃÀå ¿ªÇÐ, ±ÔÁ¦, µ¿Ç⠺м®

  • ½ÃÀå ¿ªÇÐ
    • ¼ºÀå ÃËÁø¿äÀÎ
    • ¼ºÀå ¾ïÁ¦¿äÀÎ
    • ±âȸ
  • ¿µÇ⠺м®
  • ½ÃÀå µ¿Çâ
  • ±ÔÁ¦ ½Ã³ª¸®¿À
  • Àμö¿Í Á¦ÈÞ ½Ã³ª¸®¿À
  • ÀÚ±ÝÁ¶´Þ°ú ÅõÀÚ
  • PEST ºÐ¼®
  • PorterÀÇ Five Forces ºÐ¼®

Á¦4Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå - Äڷγª¹ÙÀÌ·¯½º(COVID-19) ÆÒµ¥¹ÍÀÇ ¿µÇâ

  • ÀüüÀûÀÎ ¿µÇâ
  • Á¤ºÎ ÀÌ´Ï¼ÅÆ¼ºê
  • ½ÃÀå¿¡ ´ëÇÑ COVID-19ÀÇ ¿µÇâ

Á¦5Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå, Á¦Ç°º°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ÆäÀ̽º¸ÞÀÌÄ¿
  • Á¦¼¼µ¿±â
  • ½ÉÀåÀ絿±âÈ­ ¿ä¹ý ±â±â

Á¦6Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå, ¿ëµµº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ¿ïÇ÷¼º ½ÉºÎÀü
  • ºÎÁ¤¸Æ
  • ¼­¸Æ
  • ºó¸Æ
  • ±âŸ

Á¦7Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå, ÃÖÁ¾»ç¿ëÀÚº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • º´¿ø
  • ½ÉÀåÄɾÅÍ
  • ¿Ü·¡¼ö¼ú¼¾ÅÍ(ASC)
  • ±âŸ

Á¦8Àå ¼¼°èÀÇ ½ÉÀå ¹Úµ¿ °ü¸® ÀåÄ¡ ½ÃÀå, Áö¿ªº°, 2020-2032³â(10¾ï ´Þ·¯)

  • ¼­·Ð
  • ºÏ¹Ì
  • ¶óƾ¾Æ¸Þ¸®Ä«
  • À¯·´
  • ¾Æ½Ã¾ÆÅÂÆò¾ç
  • Áßµ¿
  • ¾ÆÇÁ¸®Ä«

Á¦9Àå °æÀï ±¸µµ

  • ±â¾÷ °³¿ä
    • Abbott Laboratories
    • Abiomed
    • BIoTronik SE &Co. KG
    • Boston Scientific Corporation
    • Koninklijke Philips NV
    • LivaNova PLC
    • Medtronic PLC
    • Schiller AG
    • Physio-Control, Inc.
    • Progetti Srl
    • Zoll Medical Corporation
    • Cardiac Science
    • Defibtech, LLC
    • Asahi Kasei Corporation
    • MicroPort Scientific Corporation
    • St. Jude Medical, Inc.
    • CU Medical Systems Inc.

Á¦10Àå ¾Ö³Î¸®½ºÆ® Ãßõ »çÇ×

  • À¶¼º°ú ¼èÅð
  • Coherent Opportunity Map

Á¦11Àå Á¶»ç ¹æ¹ý

  • Âü°í ¹®Çå
  • Á¶»ç ¹æ¹ý
LSH 25.04.01

Global Cardiac Rhythm Management Devices Market is estimated to be valued at USD 18.25 Bn in 2025 and is expected to reach USD 24.35 Bn by 2032, growing at a compound annual growth rate (CAGR) of 4.2% from 2025 to 2032.

Report Coverage Report Details
Base Year: 2024 Market Size in 2025: USD 18.25 Bn
Historical Data for: 2020 To 2024 Forecast Period: 2025 To 2032
Forecast Period 2025 to 2032 CAGR: 4.20% 2032 Value Projection: USD 24.35 Bn
Figure. Cardiac Rhythm Management Devices Market Share (%), By Region 2025
Cardiac Rhythm Management Devices Market - IMG1

Cardiac rhythm management includes diagnosis, treatment, and prevention of fast, slow, or irregular heartbeats. Rising prevalence of cardiovascular diseases and growing geriatric population worldwide can boost demand for cardiac rhythm management devices. Technological advancements have enabled development of miniaturized implantable devices, offering improved quality of life to patients. However, high costs of surgical procedures and devices can hamper the market growth. Cardiac rhythm management devices market growth is driven by rising product approvals and expansions in emerging nations.

Market Dynamics:

Global cardiac rhythm management devices market growth is driven by rising prevalence of cardiovascular disorders associated with heart rhythm abnormalities and technological advancements leading to development of sophisticated implantable devices. According to WHO, cardiovascular diseases account for over 17 million deaths annually, a majority of which are caused due to irregular heartbeats. Growing geriatric population also drives the market growth, as aging increases risk of developing arrhythmias. However, high costs of sophisticated implantable devices and surgical procedures to implant them can hamper the market growth. Market players can witness new opportunities by gaining approvals for innovative devices in newer applications and expanding to emerging countries in Asia Pacific, Latin America, and Middle East & Africa through distributor partnerships and JVs.

Key Features of the Study:

This report provides in-depth analysis of the global cardiac rhythm management devices market, and provides market size (USD Billion) and compound annual growth rate (CAGR%) for the forecast period (2025-2032), considering 2024 as the base year

It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market

This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players

It profiles key players in the global cardiac rhythm management devices market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies

Key companies covered as a part of this study include Medtronic, Abbott, Boston Scientific, Biotronik, and LivaNova

Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics

Global cardiac rhythm management devices market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts

Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global cardiac rhythm management devices market

Detailed Segmentation-

  • By Product
    • Pacemakers
    • Defibrillators
    • Cardiac Resynchronization Therapy Devices
  • By Application
    • Congestive heart failure
    • Arrhythmias
    • Bradycardia
    • Tachycardia Others
  • By End User
    • Hospitals
    • Cardiac care centers
    • Ambulatory surgical centers
    • Others
  • By Region
    • North America
    • Europe
    • Asia Pacific
    • Latin America
    • Middle East
    • Africa
  • Company Profiles:
    • Abbott Laboratories
    • Abiomed
    • Biotronik SE & Co. KG
    • Boston Scientific Corporation
    • Koninklijke Philips NV
    • LivaNova PLC
    • Medtronic PLC
    • Schiller AG
    • Physio-Control, Inc.
    • ProgettiSrl
    • Zoll Medical Corporation
    • Cardiac Science
    • Defibtech, LLC
    • Asahi Kasei Corporation
    • MicroPort Scientific Corporation
    • Jude Medical, Inc.
    • CU Medical Systems Inc.

Table of Contents

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Snapshot, By Product
    • Market Snapshot, By Application
    • Market Snapshot, By End User
    • Market Snapshot, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Market Trends
  • Key Developments
  • Regulatory Scenario
  • Acquisitions and Partnerships Scenario
  • Funding and Investments
  • PEST Analysis
  • Porter's Analysis

4. Global Cardiac Rhythm Management Devices Market- Impact of Coronavirus (COVID-19) Pandemic

  • Overall Impact
  • Government Initiatives
  • COVID-19 Impact on the Market

5. Global Cardiac Rhythm Management Devices Market, By Product, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Pacemakers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Defibrillators
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiac Resynchronization Therapy Devices
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

6. Global Cardiac Rhythm Management Devices Market, By Application, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Congestive heart failure
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Arrhythmias
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Bradycardia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Tachycardia
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

7. Global Cardiac Rhythm Management Devices Market, By End User, 2020 - 2032, (USD Bn)

  • Overview
    • Market Share Analysis, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, 2021 - 2032
    • Segment Trends
  • Hospitals
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Cardiac care centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Ambulatory Surgical Centers
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)
  • Others
    • Overview
    • Market Size and Forecast, and Y-o-Y Growth, 2020-2032, (USD Bn)

8. Global Cardiac Rhythm Management Devices Market, By Region, 2020 - 2032, (USD Bn)

  • Introduction
    • Market Share Analysis, By Region, 2025 and 2032 (%)
    • Y-o-Y Growth Analysis, For Region, 2021-2032
    • Regional Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.S.
      • Canada
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • Brazil
      • Mexico
      • Argentina
      • Rest of Latin America
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • U.K.
      • Germany
      • Italy
      • France
      • Spain
      • Russia
      • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • China
      • India
      • Japan
      • ASEAN
      • Australia
      • South Korea
      • Rest of Asia Pacific
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2020 - 2032, (USD Bn)
      • GCC Countries
      • Israel
      • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Application, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By End User, 2020 - 2032, (USD Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020 - 2032, (USD Bn)
      • North Africa
      • Central Africa
      • South Africa

9. Competitive Landscape

  • Company Profiles
    • Abbott Laboratories
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Abiomed
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Biotronik SE & Co. KG
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Boston Scientific Corporation
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Koninklijke Philips NV
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • LivaNova PLC
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Medtronic PLC
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Schiller AG
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Physio-Control, Inc.
      • Company Highlights
      • Method Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Progetti Srl
    • Zoll Medical Corporation
    • Cardiac Science
    • Defibtech, LLC
    • Asahi Kasei Corporation
    • MicroPort Scientific Corporation
    • St. Jude Medical, Inc.
    • CU Medical Systems Inc.

10. Analyst Recommendations

  • Wheel of Fortune
  • Analyst View
  • Coherent Opportunity Map

11. Research Methodology

  • References
  • Research Methodology
  • About us and Sales Contact
ºñ±³¸®½ºÆ®
0 °ÇÀÇ »óǰÀ» ¼±Åà Áß
»óǰ ºñ±³Çϱâ
Àüü»èÁ¦